Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 223 is a human protein encoded by the ZNF223 gene, located on chromosome 19. It contains a Kruppel-associated box (KRAB) domain and multiple zinc finger motifs, characteristic of a large family of DNA-binding transcription factors. While the precise biological function of ZNF223 has not yet been determined, by analogy to other KRAB zinc finger proteins, it is presumed to play a role in transcriptional regulation through sequence-specific DNA binding[3][4][7]. There is no evidence that ZNF223 itself is a therapeutic target, biomarker, or is targeted by any approved drugs. The gene has several known paralogues and belongs to a diverse protein family that is prominent in gene expression regulation[1][2][3][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 223 (ZNF223).